Dexmedetomidine: the first new kid on the block for preventing cardiac surgery-associated acute kidney injury?
Main Authors: | Patrick M. Honore, David De Bels, Thierry Preseau, Herbert D. Spapen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Critical Care |
Online Access: | http://link.springer.com/article/10.1186/s13054-018-2072-3 |
Similar Items
-
Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
by: Patrick M. Honore, et al.
Published: (2018-08-01) -
Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
by: Patrick M. Honore, et al.
Published: (2018-08-01) -
Clinical benefit of high-volume hemofiltration in severe burn injury: is it removing bad humors or actually avoiding hypervolemia?
by: Patrick M. Honore, et al.
Published: (2018-11-01) -
Hyperchloremia-associated acute chronic kidney injury: beware of confounders!
by: Patrick M. Honore, et al.
Published: (2019-01-01) -
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
by: Patrick M. Honore, et al.
Published: (2018-09-01)